Yes, several financing options exist for exoskeleton purchases, including equipment leasing, business loans, grants, and manufacturer financing programs. Companies can choose from traditional equipment financing, specialised medical device loans, or explore government funding for workplace safety improvements. The best option depends on your budget, business size, and intended use of the exoskeleton technology.
What financing options are actually available for exoskeleton purchases?
Multiple financing pathways make exoskeleton technology accessible to businesses of various sizes. Equipment leasing allows you to use exoskeletons while spreading costs over time, while business equipment loans provide ownership from day one. Many manufacturers also offer direct financing programs with flexible terms.
Traditional business equipment financing works similarly to other industrial equipment purchases. Banks and equipment finance companies understand that exoskeletons represent productivity investments, making approval processes straightforward for established businesses with good credit.
Specialised medical device financing becomes relevant when exoskeletons serve therapeutic or rehabilitation purposes. These programs often feature longer repayment terms and lower interest rates, recognising the healthcare application of the technology.
Government funding opportunities focus on workplace safety improvements. Many regions offer grants or low-interest loans for technologies that reduce workplace injuries, making exoskeletons attractive candidates for public funding support.
How much do exoskeletons typically cost and what affects the price?
Exoskeleton prices range from £15,000 for basic passive models to £100,000+ for advanced powered systems. Technology complexity drives the biggest price differences, with passive spring-based systems costing significantly less than powered robotic versions. Customisation needs, training requirements, and ongoing support services add to the total investment.
Basic passive exoskeletons for back support or lifting assistance typically cost £15,000–£40,000. These systems use springs and mechanical advantage without batteries or motors, keeping costs lower while providing meaningful ergonomic benefits.
Powered exoskeletons with motors, sensors, and control systems range from £50,000–£150,000. These advanced systems provide active assistance but require more complex engineering, resulting in higher purchase prices and maintenance costs.
Customisation significantly affects pricing. Off-the-shelf models cost less than systems tailored to specific applications or user requirements. Training programs, warranty extensions, and technical support packages can add 20–30% to the base equipment cost.
What’s the difference between leasing and buying an exoskeleton?
Leasing requires lower upfront costs and often includes maintenance, while buying provides ownership and potential tax benefits. Leasing payments typically run 20–30% of the purchase price annually, making expensive technology more accessible. Purchasing makes sense for long-term use, while leasing suits pilot programs or evolving technology needs.
Leasing advantages include predictable monthly payments, included maintenance coverage, and upgrade flexibility. When new technology emerges, you can transition to updated systems without disposing of owned equipment. This approach works well for companies testing exoskeleton implementation.
Purchasing provides ownership benefits including depreciation deductions, no usage restrictions, and long-term cost savings. After 3–4 years, ownership typically costs less than continued leasing. You also gain complete control over maintenance schedules and system modifications.
Small businesses often prefer leasing to preserve working capital, while larger organisations with established exoskeleton programs typically purchase equipment. Consider your technology refresh cycle and budget constraints when deciding between options.
How do you calculate the ROI of exoskeleton investments?
Calculate exoskeleton ROI by measuring reduced injury costs, decreased workers’ compensation claims, and improved productivity against the total investment. Most organisations see positive returns within 12–24 months through lower insurance premiums, reduced absenteeism, and increased worker efficiency. Track quantifiable benefits like fewer sick days and higher output rates.
Injury cost reduction provides the most significant savings. Workplace back injuries average £15,000–£50,000 in direct costs, not including productivity losses and replacement worker training. Preventing just one serious injury often justifies the exoskeleton investment.
Productivity improvements vary by application but typically range from 10–25% in physically demanding tasks. Workers using exoskeletons can maintain higher performance levels throughout shifts, reducing fatigue-related slowdowns and quality issues.
Workers’ compensation premium reductions reward proactive safety investments. Many insurers offer discounts for companies implementing ergonomic technologies, providing ongoing savings that improve ROI calculations over time.
Are there grants or subsidies available for workplace exoskeleton adoption?
Government grants and safety incentive programs support exoskeleton adoption in many regions. Workplace safety grants often cover 25–50% of equipment costs, while workers’ compensation insurers may offer premium discounts. Industry-specific programs target high-risk sectors like manufacturing, construction, and healthcare.
National and regional safety agencies provide grants for injury prevention technologies. These programs typically require demonstrating potential injury reduction and may include reporting requirements on safety outcomes and worker feedback.
Workers’ compensation insurers increasingly offer financial incentives for proactive safety measures. Some provide direct rebates for exoskeleton purchases, while others reduce premium rates for companies implementing ergonomic technologies.
Application processes usually require safety assessments, implementation plans, and outcome measurement commitments. Funding amounts vary by program size and available budgets, with typical grants covering £5,000–£25,000 per application.
How Intespring helps with exoskeleton financing solutions
We support customers through the entire financing process, from initial cost-benefit analysis to implementation funding. Our approach combines technical expertise with financial planning to help you make informed investment decisions that align with your operational needs and budget constraints.
Our financing support includes:
- Partnership connections with equipment financing providers who understand exoskeleton technology
- Flexible payment arrangements, including leasing options and phased implementation programs
- Comprehensive demonstration programs that help justify investment decisions to stakeholders
- Detailed ROI calculations based on your specific workplace conditions and safety objectives
- Grant application assistance and guidance on available funding opportunities
Ready to explore financing options for your exoskeleton investment? Contact us to discuss your specific requirements and learn how we can help structure a financing solution that makes advanced ergonomic technology accessible for your organisation.